GC13993
Terazosin HCl
Also known as [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;dihydrate;hydrochloride
Terazosin HCl is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist
ChemicalCAS70024-40-7MW459.92FormulaC19H25N5O4·HCl·2H2O
- CAS number
- 70024-40-7
- Molecular weight
- 459.92
- Formula
- C19H25N5O4·HCl·2H2O
- Solubility
- ≥ 23·0mg/mL in DMSO
- InChIKey
- NZMOFYDMGFQZLS-UHFFFAOYSA-N
- Catalogue number
- GC13993
- Brand
- GLPBIO
Computed properties PubChem CID 63016 · TPSA 105 Ų · H-bond donors 4 · H-bond acceptors 10
- TPSA
- 105 Ų
- H-bond donors
- 4
- H-bond acceptors
- 10
- Rotatable bonds
- 4
- Heavy atoms
- 31
SMILES COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC.O.O.Cl
Computed descriptors from PubChem (CID 63016), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il